Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Food & Drug AdministrationGHK-Cu is not an FDA-approved drug for injection
Compounded GHK-Cu is not an FDA-approved drug product
No serious adverse events have been documented in research settings no organ toxicity, no hormonal disruption, no cardiac complications, and no major drug interactions
The combination enables investigation of VEGFR2-mediated growth factor signalling alongside actin cytoskeleton dynamics, offering researchers comprehensive tools for studying complex cellular processes
US$ 22.26
US$ 28.92
US$ 26.18
US$ 23.45
US$ 28.35
US$ 28.88
US$ 22.29
US$ 26.60
